Sotgiu et al. observed, in 66 patients with stroke, an inverse relationship between the early IL-6 levels, the size of the lesion and the neurological result of the patient, which indicates that initial IL-6 has a neuroprotective effect and is not a marker of disease progression [28]. This evidence concerns the gene IL6 and Stroke.